S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
Log in
CVE:COT

Cotinga Pharmaceuticals Inc. (COT.V) Stock Forecast, Price & News

C$0.04
-0.03 (-41.67 %)
(As of 10/14/2020)
Add
Compare
Today's Range
C$0.04
Now: C$0.04
C$0.04
50-Day Range
C$0.04
MA: C$0.03
C$0.04
52-Week Range
C$0.02
Now: C$0.04
C$0.12
Volume1,000 shs
Average Volume20,281 shs
Market CapitalizationC$769,510.00
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-519-8585157
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$0.00 per share
Book ValueC($0.18) per share

Profitability

Miscellaneous

Market CapC$769,510.00
Next Earnings Date4/7/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

0.54 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
C$0.04
-0.03 (-41.67 %)
(As of 10/14/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive COT News and Ratings via Email

Sign-up to receive the latest news and ratings for COT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) Frequently Asked Questions

What stocks does MarketBeat like better than Cotinga Pharmaceuticals Inc. (COT.V)?

Wall Street analysts have given Cotinga Pharmaceuticals Inc. (COT.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cotinga Pharmaceuticals Inc. (COT.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Cotinga Pharmaceuticals Inc. (COT.V)'s next earnings date?

Cotinga Pharmaceuticals Inc. (COT.V) is scheduled to release its next quarterly earnings announcement on Wednesday, April 7th 2021.
View our earnings forecast for Cotinga Pharmaceuticals Inc. (COT.V)
.

How has Cotinga Pharmaceuticals Inc. (COT.V)'s stock price been impacted by Coronavirus (COVID-19)?

Cotinga Pharmaceuticals Inc. (COT.V)'s stock was trading at C$0.03 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, COT shares have increased by 16.7% and is now trading at C$0.04.
View which stocks have been most impacted by COVID-19
.

Is Cotinga Pharmaceuticals Inc. (COT.V) a good dividend stock?

Cotinga Pharmaceuticals Inc. (COT.V) pays an annual dividend of C$0.24 per share and currently has a dividend yield of 0.00%.
View Cotinga Pharmaceuticals Inc. (COT.V)'s dividend history.

Who are Cotinga Pharmaceuticals Inc. (COT.V)'s key executives?

Cotinga Pharmaceuticals Inc. (COT.V)'s management team includes the following people:
  • Ms. Alison D. Silva, CEO, Pres & Director
  • Dr. Richard T. Ho, Chief Scientific Officer (Age 58, Pay $323.16k)
  • Mr. Victor Hugo C.M.A., C.P.A., Chief Financial Officer (Age 51)
  • Mr. Paul Papi, VP of Investor Relations

Who are some of Cotinga Pharmaceuticals Inc. (COT.V)'s key competitors?

What other stocks do shareholders of Cotinga Pharmaceuticals Inc. (COT.V) own?

What is Cotinga Pharmaceuticals Inc. (COT.V)'s stock symbol?

Cotinga Pharmaceuticals Inc. (COT.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "COT."

How do I buy shares of Cotinga Pharmaceuticals Inc. (COT.V)?

Shares of COT and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Cotinga Pharmaceuticals Inc. (COT.V)'s stock price today?

One share of COT stock can currently be purchased for approximately C$0.04.

How much money does Cotinga Pharmaceuticals Inc. (COT.V) make?

Cotinga Pharmaceuticals Inc. (COT.V) has a market capitalization of C$769,510.00.

What is Cotinga Pharmaceuticals Inc. (COT.V)'s official website?

The official website for Cotinga Pharmaceuticals Inc. (COT.V) is cotingapharma.com.

Where are Cotinga Pharmaceuticals Inc. (COT.V)'s headquarters?

Cotinga Pharmaceuticals Inc. (COT.V) is headquartered at 100 Collip Cir Suite 230B, LONDON, ON N6G 4X8, Canada.

How can I contact Cotinga Pharmaceuticals Inc. (COT.V)?

Cotinga Pharmaceuticals Inc. (COT.V)'s mailing address is 100 Collip Cir Suite 230B, LONDON, ON N6G 4X8, Canada. The company can be reached via phone at +1-519-8585157.


This page was last updated on 2/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.